RxDoctor Payments Data

Eugene Vortsman, DO

Addiction Medicine · New Hyde Park, NYNPI 1730523069

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $5,000 of the $5,624 with a category attached, or 88.9%. Eagle Pharmaceuticals, Inc. accounts for 88.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $5,023 and has fallen 92.8% since, to $361 in 2025.

$5,624in general payments, 2019–2025

Across 12 payments — averaging $468.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eagle Pharmaceuticals, Inc.$5K
  • GRT US Holding, Inc.$169
  • Lundbeck LLC$140
  • Vertex$95
  • Redhill Biopharma Inc.$71
  • CSL Behring$66
  • plus $83 from 2 others

What the payments were for

  • Speaking & faculty fees$5,00089%
  • Food & beverage$62411%

General payments by program year

21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,624 in reported general payments places this provider in the 85th percentile of 125 addiction medicine providers in New York.

See all addiction medicine providers in New York

Medicare billing

Part B allowed, 2024
$62,743
Medicare patients
356
Services billed
377

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other addiction medicine in New Hyde Park

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →